Kennedy, a top health official, urges ‘cautious approach’ after Trump baselessly claimed taking Tylenol is linked autism in children.

United States Health and Human Services Secretary Robert F Kennedy Jr has partially walked back his warning that taking Tylenol during pregnancy is directly linked to autism in children.

In a news conference on Wednesday, Kennedy struck a more moderate tone than he generally has in his past public appearances.

“The causative association between Tylenol given in pregnancy and the perinatal periods is not sufficient to say it definitely causes autism,” Kennedy told reporters. “But it’s very suggestive.”

“There should be a cautious approach to it,” he added. “ That’s why our message to patients, to mothers, to people who are pregnant and to the mothers of young children is: Consult your physician.”

Wednesday’s statement is closer in line with the guidance of reputable health agencies.

While some studies have raised the possibility of a link between Tylenol and autism, there have been no conclusive findings. Pregnant women are advised to consult a doctor before taking the medication.

The World Health Organization reiterated the point in September, noting that “no consistent association has been established” between the medication and autism, despite “extensive research”.

But claims to the contrary have already prompted efforts to limit the availability of Tylenol, a popular brand of acetaminophen, a fever- and pain-reducing medication.

On Tuesday, Texas Attorney General Ken Paxton launched a lawsuit accusing Johnson & Johnson and Kenvue, the companies behind the over-the-counter pain reliever, of deceptive practices.

In doing so, he reiterated misinformation shared by President Donald Trump and government officials like Kennedy.

“By holding Big Pharma accountable for poisoning our people, we will help Make America Healthy Again,” Paxton said in a statement, giving a nod to Kennedy’s MAHA slogan.

The suit alleges that Johnson & Johnson and Kenvue violated Texas consumer protection laws by having “deceptively marketed Tylenol as the only safe painkiller for pregnant women”.

It was the latest instance of scientific misinformation being perpetuated by top officials. Both Trump and Kennedy have repeatedly spread scientific misinformation throughout their political careers.

Trump linked autism and the painkiller during a news conference in September, without providing reputable scientific findings to back the claim.

“[Using] acetaminophen – is that OK? – which is basically, commonly known as Tylenol, during pregnancy can be associated with a very increased risk of autism,” Trump said on September 22. “So taking Tylenol is not good. I’ll say it. It’s not good.”

Kennedy has offered his own sweeping statements about Tylenol and its alleged risks, despite having no professional medical background.

“Anyone who takes this stuff during pregnancy, unless they have to, is irresponsible,” he said in a cabinet meeting on October 9.

Kennedy also mischaracterised studies on male circumcision earlier this month. He falsely said the studies showed an increase in autism among children who were “circumcised early”.

“It’s highly likely because they’re given Tylenol,” he added.

Kenvue stressed in a statement on Tuesday that acetaminophen is the safest pain reliever option for pregnant women, noting that high fevers and pain are potential risks to pregnancies if left untreated.

“We stand firmly with the global medical community that acknowledges the safety of acetaminophen and believe we will continue to be successful in litigation as these claims lack legal merit and scientific support,” Kenvue said.

LOS ANGELES (AP) — A federal judge disqualified acting U.S. Attorney Bill Essayli in Southern California from several cases after concluding Tuesday that the Trump appointee has stayed in the temporary job longer than allowed by law.

U.S. District Judge J. Michael Seabright disqualified Essayli from supervising the criminal prosecutions in three cases, siding with defense lawyers. Essayli has been unlawfully serving as acting U.S. attorney for the Central District of California since July 29, Seabright wrote. But he may continue to serve as a First Assistant United States Attorney, Seabright ruled, effectively leaving him as the office’s top prosecutor.

“Nothing is changing,” Essayli wrote in a social media post Tuesday evening, saying he looked forward to advancing President Donald Trump’s agenda.

The decision represents another setback to the Trump administration’s effort to extend handpicked acting U.S. attorneys beyond the 120-day limit set by federal law. A judge ruled in September that acting U.S. attorney of Nevada, Sigal Chattah, was serving in her position illegally. Another judge disqualified acting U.S. attorney in New Jersey, Alina Habba, in August.

Essayli is a former federal prosecutor turned Republican California Assemblymember, where he took up conservative causes and criticized the state’s COVID-19 restrictions. He has been outspoken against California policies to protect immigrants living in the country illegally, and he has aggressively prosecuted people who protest Trump’s ramped up immigration enforcement across Southern California.

Under federal law, if a permanent U.S. attorney is not nominated by the president and confirmed by the Senate within 120 days, judges of the federal district court can appoint an interim until the vacancy is filled. Essayli has not been confirmed by the U.S. Senate —something that generally requires a degree of bipartisan support. California Sens. Adam Schiff and Alex Padilla have criticized Essayli’s appointment.

Essayli was appointed as interim U.S. attorney in March, several months after former President Joe Biden’s appointee to the job resigned. Just shy of the 120-day mark, U.S. Attorney General Pam Bondi appointed him as First Assistant U.S. Attorney and said he would have the authority to serve as acting U.S. attorney upon a vacancy in the role. He then resigned as interim U.S. attorney.

The government has argued that he can do so under the Federal Vacancies Reform Act of 1998, which Congress passed specifically to regulate the temporary filling of executive branch vacancies that require presidential appointment and Senate confirmation.

Seabright, however, said that provision of the law only applies if the previous U.S. Attorney dies, resigns, or is otherwise incapacitated.

The lawsuit seeking to disqualify Essayli was brought by three men facing federal firearms charges. They sought to have their indictments dismissed. Seabright ruled the indictments can proceed.

In Nevada, the same judge that disqualified Chattah ruled last week that he was pausing his earlier ruling while a federal appellate court weighed an appeal from the U.S. Department of Justice, allowing her to remain temporarily involved in the cases being prosecuted by her office. An appellate court heard arguments on Monday regarding Habba’s appointment as well, questioning government lawyers on their maneuvers to keep Habba in place.

U.S. President Donald Trump on Wednesday met with South Korean President Lee Jae Myung in the city of Gyeongju – the final stop on his Asia tour aimed at securing new investment deals. 

“The Republic of Korea is a cherished American friend and a close ally. And as we can see in this beautiful city, it’s truly one of the most remarkable nations anywhere on earth,” Trump said ahead of the meeting at the Asia-Pacific Economic Cooperation (APEC) CEO Summit, adding that South Korea’s president “is a terrific person.”

During their bilateral meeting, Lee asked Trump to consider allowing South Korea to access fuel for conventionally armed, nuclear-powered submarines – a long-standing restriction under a U.S. nonproliferation deal. 

Trump’s previous stops during his trip included visits to Malaysia and Japan.

After his visit to Japan yielded roughly $490 billion in investment commitments, Trump said a trade deal with South Korea has proven more challenging as he seeks an additional $350 billion in U.S. investments. Trump predicted total new investment could reach upwards of $22 trillion in investments by the end of his first year back in the White House.

TRUMP’S FOCUS TURNS TO JAPAN AND SOUTH KOREA AS ASIA TRIP CONTINUES

“I figure that we’ll probably be at 20 or 21, maybe even $22 trillion of investments coming into our country by the end of the first year of my second term,” the president said. “And we had a tremendously successful first term. We had the strongest economy in history for our country, the strongest we ever had. But this is, I think, blowing it away. We have a great policy. We have some very good things happening.”

“Around the world, we’re signing one trade deal after another to balance our relationships on the basis of reciprocity,” Trump added. “I’ve signed groundbreaking agreements with Malaysia, Cambodia, Japan, and our deal with the Republic of Korea will be finalized very soon. These agreements will be incredible victories for all of us, because everyone is better off when we have stable partnerships not plagued by chronic problems and imbalances.”

Speaking to business executives at the event, Trump described an “economic revolution” underway in the United States. The president urged the executives not to listen to “small minds with no vision,” pledging to “build, trade, prosper and thrive together.” 

TRUMP ANNOUNCES MEETING WITH XI JINPING AT SOUTH KOREA APEC SUMMIT SCHEDULED FOR NEXT MONTH

U.S. President Donald Trump shakes hands with South Korean President Lee Jae Myung as they attend a high honor ceremony at the Gyeongju National Museum in Gyoeongju, South Korea. (AP)

Trump later received South Korea’s Grand Order of Mugunghwa – the nation’s highest honor – along with a replica of a royal crown from the ancient Silla Kingdom, symbolizing Seoul’s recognition of his prior diplomatic efforts. 

Trump’s visit coincided with new tensions on the Korean Peninsula after North Korea said it fired sea-to-surface cruise missiles off its western coast. 

“He’s been launching missiles for decades, right?” Trump said of North Korean leader Kim Jong Un.

Trump reiterated his willingness to meet with the North’s leader, saying, “We had a really good understanding of each other.” 

U.S. President Donald Trump waves after speaking at the Asia-Pacific Economic Cooperation CEO summit in Gyeongju, South Korea. (AP)

In a separate speech, South Korea’s leader warned against rising protectionism, urging global cooperation on trade – a message that contrasted with Trump’s America First pitch. 

Trump also previewed his upcoming meeting with Chinese President Xi Jinping.

“You know that President Xi of China is coming here tomorrow, and we’re going to be, I hope, making a deal,” Trump said. “I think we’re going to have a deal. I think it’ll be a good deal for both. And that’s really a great result.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“That’s better than fighting and having all sorts of problems. And, you know, no reason for it,” he added.

The Associated Press contributed to this report.